+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

United States Proton Therapy Market & Forecast, Reimbursement Policy, Patients Treated at Proton Therapy Centers

  • ID: 4188639
  • Report
  • March 2017
  • Region: United States
  • 72 Pages
  • Renub Research
1 of 5

Enquire about COVID-19 updates for this product.

Enquire Now
Potential Market of Proton Therapy in United States Would Be More Than Us$ 15 Billion by the End of 2021 and it is Expected to Grow With a CAGR of 6.04 Percent

FEATURED COMPANIES

  • Bloomington (MPRI, 2)
  • CDH Warrenville
  • Houston (MD Anderson)
  • Memphis (St. Jude PTC)
  • Proton Therapy Centers:
  • UCSF - CNL
  • MORE

The potential market of proton therapy in United States would be more than US$ 15 Billion by the end of 2021 and it is expected to grow with a CAGR of 6.04 percent in future. At present the United States holds world’s 40 percent of Proton Beam Therapy Facility. In recent time, more research institutes and hospitals are investing in proton therapy to make the technology more accessible to patients.

In this report we have studied the market in two parts: a) Actual Market and b) Potential Market. The report also talks about list of all operational and future Proton Therapy centers; Economics of proton therapy including reimbursement policies. Proton Therapy revenues from 3 companies (IBA, Varian Medical Systems, Elekta) has also been studied in the report.

a) Actual Market is the current market which is already present

b) Potential Market is the market which can be achieved; but it has yet not been achieved due to demand and supply gap. At present only a few proton therapy centers are available that can treat a limited number of patients each year.

United States Proton Therapy Market has been analyzed from four view points:

  • United States Proton Therapy Actual Market & Forecast (2009 - 2021)
  • United States Proton Therapy Untapped Market & Forecast (2009 - 2021)
  • United States Proton Therapy Treated Patient Volume & Forecast (2009 - 2021)
  • United States Proton Therapy Untapped Patient Volume & Forecast (2009 - 2021)

Key Companies Covered:

  • IBA (Overview, Sales Analysis)
  • Varian Medical Systems (Overview, Sales Analysis)
  • Elekta (Overview, Sales Analysis)

Note: This report offers 10% free customization.
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Bloomington (MPRI, 2)
  • CDH Warrenville
  • Houston (MD Anderson)
  • Memphis (St. Jude PTC)
  • Proton Therapy Centers:
  • UCSF - CNL
  • MORE

1. Executive Summary

2. United States Proton Therapy Market - Actual & Potential Market
    2.1 United States - Proton Therapy Market
    2.2 United States - Potential Proton Therapy Market & Forecast

3. United States Proton Therapy Patient Number - Actual and Potential
    3.1 United States - Patients Treated with Proton Therapy Actual Numbers & Forecast
    3.2 United States - Patients with Proton Therapy Potential Numbers & Forecast

4. United States - List of Proton Therapy Centers

5. United States - Proton Therapy Treated Patients by Centers
    5.1 Loma Linda (LLUMC) Proton Therapy Center - Number of Patients Treated (2008 - 2014)
    5.2 UCSF - CNL Proton Therapy Center - Number of Patients Treated (2008 - 2015)
    5.3 Boston (NPTC) Proton Therapy Center - Number of Patients Treated (2008 - 2015)
    5.4 Bloomington (MPRI, 2) Proton Therapy Center - Number of Patients Treated (2008 - 2014)
    5.5 Houston (MD Anderson) Proton Therapy Center - Number of Patients Treated (2008 - 2015)
    5.6 UFPTI Jacksonville Proton Therapy Center - Number of Patients Treated (2008 - 2015)
    5.7 Oklahoma City (ProCure PTC) Proton Therapy Center - Number of Patients Treated (2009 - 2015)
    5.8 CDH Warrenville Proton Therapy Center - Number of Patients Treated (2010 - 2015)
    5.9 Philadelphia (Upenn) Proton Therapy Center - Number of Patients Treated (2011 - 2015)
    5.10 Hampton (HUPTI) Proton Therapy Center - Number of Patients Treated (2012 - 2015)
    5.11 New Jersey (ProCure PTC) Proton Therapy Center - Number of Patients Treated (2012 - 2015)
    5.12 Seattle (SCCA ProCure PTC) Proton Therapy Center - Number of Patients Treated (2013 - 2015)
    5.13 St. Louis (S. Lee King PTC) Proton Therapy Center - Number of Patients Treated (2013 - 2015)
    5.14 Provision Center for Proton Therapy, Knoxville, TN - Number of Patients Treated (2014 - 2015)
    5.15 San Diego (Scripps PTC) - Number of Patients Treated (2014 - 2015)
    5.16 Shreveport (Willis Knighton) Proton Therapy Center - Number of Patients Treated (2014 - 2015)
    5.17 Jacksonville (Ackerman CC) Proton Therapy Center - Number of Patients Treated (2015)
    5.18 Rochester (Mayo PBTC) Proton Therapy Center - Number of Patients Treated (2015)
    5.19 Brunswick (Laurie PC) Proton Therapy Center - Number of Patients Treated (2015)
    5.20 Irving (Texas Center for PT) Proton Therapy Center - Number of Patients Treated (2015)
    5.21 Memphis (St. Jude PTC) Proton Therapy Center - Number of Patients Treated (2015)

6. Proton Therapy - Reimbursement Policies
    6.1 Proton Therapy Reimbursement Policies for Patients
    6.2 Proton Therapy Reimbursement for Institutions, Stakeholders and Manufacturers

7. Components of a Standard Proton Therapy Center
    7.1 Proton Accelerator
        7.1.1 Synchrotrons (example: LLUMC at Loma Linda)
        7.1.2 Cyclotrons (example: MGH Boston)
        7.1.3 Synchrocyclotrons (examples: Orsay, Uppsala)
        7.1.4 Linacs (Rome)
        7.1.5 H-minus Synchrotrons
        7.1.6 Separated Sector Cyclotrons
        7.1.7 Super-conducting Cyclotrons
        7.1.8 Fast Cycling Synchrotron
    7.2 Beam Transport System
    7.3 Beam Delivery System
        7.3.1 The Passive Scattering Technique
        7.3.2 Beam Scanning
    7.4 Nozzle
        7.4.1 Single Scattering
        7.4.2 Double Scattering
        7.4.3 Uniform Scanning Nozzle
        7.4.4 Pencil Scanning Nozzle
    7.5 Treatment Planning System
    7.6 Image Viewers
    7.7 Patient Positioning System (PPS)
    7.8 Human Resource

8. Global Proton Therapy - Company Analysis (2010-2021)
    8.1 IBA Proton Therapy
        8.1.1 Sales Analysis
    8.2 Varian Medical Systems
        8.2.1 Sales Analysis
    8.3 Elekta
        8.3.1 Sales Analysis

9. Proton Therapy - Driving Factors
    9.1 Technology Advancement
    9.2 Growing Incidence of Cancer Patients in United States

10. Proton Therapy - Challenges
    10.1 Requires Huge Investment
    10.2 Operations Challenges

List of Figures
Figure 2 1: United States - Proton Therapy Market (Million US$), 2009 - 2016
Figure 2 2: United States - Forecast for Proton Therapy Market (Million US$), 2017 - 2021
Figure 2 3: United States - Potential Proton Therapy Market (Million US$), 2009 - 2016
Figure 2 4: United States - Forecast for Potential Proton Therapy Market (Million US$), 2017 - 2021
Figure 3 1: United States - Patient Treated with Proton Therapy (Number), 2009 - 2016
Figure 3 2: United States - Forecast for Patient Treated with Proton Therapy (Number), 2017 - 2021
Figure 3 3: United States - Potential Candidate for Proton Therapy (Number), 2009 - 2016
Figure 3 4: United States - Forecast for Potential Candidate for Proton Therapy (Number), 2017 - 2021
Figure 8 1: Global - IBA Proton Therapy Sales (Million US$), 2010 - 2016
Figure 8 2: Global - Forecast for IBA Proton Therapy Sales (Million US$), 2017 - 2021
Figure 8 3: Global - Varian Medical Systems Oncology Systems Sales (Million US$), 2010 - 2016
Figure 8 4: Global - Forecast for Varian Medical Systems Oncology Systems Sales (Million US$), 2017 - 2021
Figure 8 5: Global - Elekta Radiation Technology Sales (Million US$), 2010 - 2016
Figure 8 6: Global - Forecast for Elekta Radiation Technology Sales (Million US$), 2017 - 2021
Figure 9 1: United States - Number of Patient Diagnosed With Cancer (Thousand), 2009 - 2016
Figure 9 2: United States - Forecast for Number of Patient Diagnosed With Cancer (Thousand), 2017 - 2021

List of Tables
Table 4 1: United States - Proton Therapy Facilities in Operation
Table 4 2: United States - Proton Therapy Centers in Under-Construction
Table 4 3: United States - Proton Therapy Centers in Planning Phase
Table 5 1: United States - Loma Linda (LLUMC) Proton Therapy Center with Patients Treated (Number), 2008 - 2014
Table 5 2: United States - UCSF - CNL Proton Therapy Center with Patients Treated (Number), 2008 - 2015
Table 5 3: United States - Boston (NPTC) Proton Therapy Center with Patients Treated (Number), 2008 - 2015
Table 5 4: United States - Bloomington (MPRI, 2) Proton Therapy Center with Patients Treated (Number), 2008 - 2014
Table 5 5: United States - Houston (MD Anderson) Proton Therapy Center with Patients Treated (Number), 2008 - 2015
Table 5 6: United States - UFPTI Jacksonville Proton Therapy Center with Patients Treated (Number), 2008 - 2015
Table 5 7: United States - Oklahoma City (ProCure PTC) Proton Therapy Center with Patients Treated (Number), 2009 - 2015
Table 5 8: United States - CDH Warrenville Proton Therapy Center with Patients Treated (Number), 2010 - 2015
Table 5 9: United States - Philadelphia (Upenn) Proton Therapy Center with Patients Treated (Number), 2011 - 2015
Table 5 10: United States - Hampton (HUPTI) Proton Therapy Center with Patients Treated (Number), 2012 - 2015
Table 5 11: United States - New Jersey (ProCure PTC) Proton Therapy Center with Patients Treated (Number), 2012 - 2015
Table 5 12: United States - Seattle (SCCA ProCure PTC) Proton Therapy Center with Patients Treated (Number), 2013 - 2015
Table 5 13: United States - St. Louis (S. Lee King PTC) Proton Therapy Center with Patients Treated (Number), 2013 - 2015
Table 5 14: United States - Provision Center for Proton Therapy, Knoxville, TN with Patients Treated (Number), 2014 - 2015
Table 5 15: United States - San Diego (Scripps PTC) with Patients Treated (Number), 2014 - 2015
Table 5 16: United States - Shreveport (Willis Knighton) Proton Therapy Center with Patients Treated (Number), 2014 - 2015
Table 5 17: United States - Jacksonville (Ackerman CC) Proton Therapy Center with Patients Treated (Number), 2015
Table 5 18: United States - Rochester (Mayo PBTC) Proton Therapy Center with Patients Treated (Number), 2015
Table 5 19: United States - Brunswick (Laurie PC) Proton Therapy Center with Patients Treated (Number), 2015
Table 5 20: United States - Irving (Texas Center for PT) Proton Therapy Center with Patients Treated (Number), 2015
Table 5 21: United States - Memphis (St. Jude PTC) Proton Therapy Center with Patients Treated (Number), 2015

Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
  • Elekta
  • IBA
  • Varian Medical Systems

Proton Therapy Centers:

  • Bloomington (MPRI, 2)
  • Boston (NPTC)
  • Brunswick (Laurie PC)
  • CDH Warrenville
  • Hampton (HUPTI)
  • Houston (MD Anderson)
  • Irving (Texas Center for PT)
  • Jacksonville (Ackerman CC)
  • Loma Linda (LLUMC)
  • Memphis (St. Jude PTC)
  • New Jersey (ProCure PTC)
  • Oklahoma City (ProCure PTC)
  • Philadelphia (Upenn)
  • Provision Center for Proton Therapy, Knoxville, TN
  • Rochester (Mayo PBTC)
  • San Diego (Scripps PTC)
  • Seattle (SCCA ProCure PTC)
  • Shreveport (Willis Knighton)
  • St. Louis (S. Lee King PTC)
  • UCSF - CNL
  • UFPTI Jacksonville
Note: Product cover images may vary from those shown
5 of 5

In this report, for analyzing the future trends for the studied market during the forecast period, the publisher has incorporated rigorous statistical and econometric methods, further scrutinized by secondary, primary sources and by in-house experts, supported through their extensive data intelligence repository. The market is studied holistically from both demand and supply-side perspectives. This is carried out to analyze both end-user and producer behavior patterns, in the review period, which affects price, demand and consumption trends. As the study demands to analyze the long-term nature of the market, the identification of factors influencing the market is based on the fundamentality of the study market.

Through secondary and primary researches, which largely include interviews with industry participants, reliable statistics, and regional intelligence, are identified and are transformed to quantitative data through data extraction, and further applied for inferential purposes. The publisher's in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of their recommendations and advice.

Primary Research

The primary purpose of this phase is to extract qualitative information regarding the market from the key industry leaders. The primary research efforts include reaching out to participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions. The publisher also established professional corporate relations with various companies that allow us greater flexibility for reaching out to industry participants and commentators for interviews and discussions, fulfilling the following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develop the analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth, and forecast

The researcher's primary research interview and discussion panels are typically composed of the most experienced industry members. These participants include, however, are not limited to:

  • Chief executives and VPs of leading corporations specific to the industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investment, and valuation experts
  • Key opinion leaders (KOLs)

Secondary Research

The publisher refers to a broad array of industry sources for their secondary research, which typically includes, however, is not limited to:

  • Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, webcasts, and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecasts
 

Loading
LOADING...

Adroll
adroll